STAAR Surgical Company (STAA)
NASDAQ • Healthcare
Last close at October 23, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q3 2026In plain terms: out of every $100 in revenue, STAAR Surgical Company keeps $9 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 4
in 10 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
STAAR Surgical’s second fiscal quarter of 2026 paired a revenue beat with an EPS miss, as results reported August 12, 2026 showed revenue of $93.5 million topped the $90.6 million estimate (+3.2%) while EPS of $0.16 trailed the $0.22 estimate (-28%). Revenue rose 111% to about $93.5 million, up from about $44.3 million a year ago, alongside a swing in per-share results from -$0.34 a year ago. Profitability came through at a gross margin of roughly 75% and an operating margin near 11%, with gross profit of about $69.7 million and operating income of roughly $10.1 million. The quarter generated operating cash flow of about $19.7 million, and the company repurchased roughly $2.7 million of stock. For the next period, consensus calls for EPS of $0.20 on revenue of $79.1 million.
Next report — what to expect
STAAR Surgical Company (STAA) reports on November 4, 2026. The market is looking for consensus EPS of $0.05 on revenue of $78.7 million. For trailing context, revenue rose +111.0% year over year last quarter. STAA has beaten EPS in 5 of 8 most recent quarters.
About STAAR Surgical Company
STAAR Surgical Company develops, manufactures, and commercializes ophthalmic devices centered on implantable lenses for vision correction, sells products used by eye-care providers across cataract and refractive procedures, and trades on the NASDAQ under STAA in the healthcare equipment and medical supplies business. In FY2025, the company generated $239.4 million in revenue.
Today's Snapshot
The day ended with STAA 0.5% higher at 22.61, outperforming a weaker sector. Trading was lighter than usual, with volume about two-thirds of its usual level. Earnings are due from STAA on 4 November.
Trading Volume
Below 10d avg (522.6K)
317.9K
vs S&P 500 Today
Outperforming Market
+1.05%
Updated: October 23, 2026 at 20:10 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$22.04 - $23.61Sell
- RSI (14)53.69Neutral
- Stochastic %K (14, 3, 3)70.86Neutral
- MACD Level (12, 26)-0.03Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.